Skip to main content
. 2017 Oct 12;38(6):3335–3346. doi: 10.3892/or.2017.6026

Figure 3.

Figure 3.

Dose-dependent decrease in cell viability of the isolated primary cells to gemcitabine. (A) Except for PC-07-0037 and PC-07-0045, most isolated primary cells were vulnerable to lower doses of gemcitabine. (B) Cells derived from the PDX models PC-07-0037 and PC-07-0045 were sensitive to higher doses of gemcitabine.